Interestingly, KRAS mutations were significantly higher in patients who were older than 50 years old in comparison with patients younger than 50 years old (45.67 % vs. 17.67 %, p < 0.001), indicating that KRAS mutations are uncommon in younger CRC patients. This evidence concerns the gene KRAS and colorectal carcinoma.